Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies

Protein Expression and Purification

Volumn 52, Issue 2, 2007, Pages 395-402

  Medynski, Dan ^a   Tuan, Michael ^a   Liu, Wayne ^a   Wu, Shili ^a   Lin, Xinli ^a  

^a ProteomTech Inc   (United States)

Author keywords

activation; E. coil expression; Inclusion bodies; Microplasmin; Miniplasmin; Refolding

Indexed keywords

MICROPLASMINOGEN PROTEIN, HUMAN; MINIPLASMINOGEN; PEPTIDE FRAGMENT; PLASMINOGEN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL INCLUSION; CHEMISTRY; ESCHERICHIA COLI; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KINETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN FOLDING; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ESCHERICHIA COLI; HUMANS; INCLUSION BODIES; KINETICS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMINOGEN; PROTEIN FOLDING; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

ESCHERICHIA COLI;

EID: 33846407211     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.10.012     Document Type: Article

References (18)

1. Christensen U., Sottrup-Jensen L., Magnusson S., Petersen T.E., and Clemmensen I. Enzymic properties of the neo-plasmin-Val-442 (miniplasmin). Biochim. Biophys. Acta 567 (1979) 472-481
2. Ney K.A., and Pizzo S.V. Fibrinolysis and fibrinogenolysis by Val442-plasmin. Biochim. Biophys. Acta 708 (1982) 218-224
3. Wu H.L., Shi G.Y., and Bender M.L. Preparation and purification of microplasmin. Proc. Natl. Acad. Sci. USA 84 (1987) 8292-8295
4. Wu H.L., Shi G.Y., Wohl R.C., and Bender M.L. Structure and formation of microplasmin. Proc. Natl. Acad. Sci. USA 84 (1987) 8793-8795
5. Wang J., and Reich E. Structure and function of microplasminogen: II. Determinants of activation by urokinase and by the bacterial activator streptokinase. Protein Sci. 4 (1995) 1768-1779
6. Novokhatny V., Taylor K., and Zimmerman T.P. Thrombolytic potency of acid-stabilized plasmin: superiority over tissue-type plasminogen activator in an in vitro model of catheter-assisted thrombolysis. J. Thromb. Haemost. 1 (2003) 1034-1041
7. Marder V.J., Landskroner K., Novokhatny V., Zimmerman T.P., Kong M., Kanouse J.J., and Jesmok G. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit. Thromb. Haemostasis 86 (2001) 739-745
8. Nagai N., Demarsin E., Van Hoef B., Wouters S., Cingolani D., Laroche Y., and Collen D. Recombinant human microplasmin: production and potential therapeutic properties. J. Thromb. Haemost. 1 (2003) 307-313
9. Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Express. Purif. 41 (2005) 207-234
10. J.V. Jensen, Process of stabilizing therapeutically useful plasmin solutions. In: US Patent & Trademark Office Patent Application Full Text and Image Database, Patent 3,950,513, Novo Terapeutisk Laboratorium A/S (DK), (1976).
11. Komorowicz E., Kolev K., and Machovich R. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors. Biochemistry 37 (1998) 9112-9118
12. Kolev K., Komorowicz E., Owen W.G., and Machovich R. Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G. Thromb. Haemostasis 75 (1996) 140-146
13. Kolev K., Komorowicz E., and Machovich R. Heparin modulation of the fibrinolytic activity of plasmin, miniplasmin and neutrophil leukocyte elastase in the presence of plasma protease inhibitors. Blood Coagul. Fibrin. 5 (1994) 905-911
14. Wiman B., and Collen D. On the kinetics of the reaction between human antiplasmin and plasmin. Eur. J. Biochem. 84 (1978) 573-582
15. Cao Y., Chen A., An S.S., Ji R.W., Davidson D., and Llinas M. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272 (1997) 22924-22928
16. Zhou Y., Zheng Q., Gao J., and Gu J. High level expression of kringle 5 fragment of plasminogen in Pichia pastoris. Biotechnol. Lett. 27 (2005) 167-171
17. Christensen U., Bangert K., and Thorsen S. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics. FEBS Lett. 387 (1996) 58-62
18. Graversen J.H., Jacobsen C., Sigurskjold B.W., Lorentsen R.H., Moestrup S.K., Thogersen H.C., and Etzerodt M. Mutational analysis of affinity and selectivity of kringle-tetranectin interaction. Grafting novel kringle affinity onto the tetranectin lectin scaffold. J. Biol. Chem. 275 (2000) 37390-37396